no one really seems interetsed in your query regarding the L1 agreement. I think its a very valid point and causes me some concern. I don't think they mentioned it in the quarterly and instead referred to soph cap raise and reducing operating expenses.
need a partnership deal that funds the future trials of CHM1101
Now would be a great time for a director or management to buy on market as some token sign of confidence
Patience is required but one shouldn't bury their head in the sand in the meantime either
no one likes to see their hard earned dollars seemingly down the gurgler....at least on paper
I believe CHM have the right team and tech and it's a matter of finance at the moment
not interested in talk of IMU investment or relisting in the US as some posters mention... US biotech is unloved as well.
Could be a tough period unitl interest rates stop increasing each month
we seem to be operating in a vacuum as thier has been no or very little said around the finances
caustiously optimistic on CHM1101 as their language seems positive but this will have to play out and such a tough disease to treat
bought a few more today but changed my sentiment to hold as the risk levels on this one are increasing and lack of clarity on financing the future can only be considered concerning
CHM Price at posting:
4.8¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)